International Cholangiocarcinoma Research Network (ICRN)

The ICRN is a global collaboration of research groups from renowned institutions that are working in concert to improve knowledge about cholangiocarcinoma etiology, prevention, early detection, treatment and prognosis. The network is comprised of highly talented individuals from a spectrum of disciplines, perspectives, and research methods who share the passion to make significant scientific advances that improve outcomes for patients with cholangiocarcinoma.

The goal of ICRN is to accelerate the clinical translation of scientific discoveries to impact the lives of patients with cholangiocarcinoma.

Upcoming Events

Asia-Pacific Conference

March 23 & 24
Bangkok, Thailand

A-P Conference website

These meetings are open to ICRN members only. Please contact Reham Ali with any questions about membership at:

ICRN Newsletters

ICRN Members Map

If your industry or biotech company or organization is interested in partnering with the ICRN for the purposes of cholangiocarcinoma research and potential collaboration, please fill out the ICRN Industry Request for Engagement form.

ICRN Executive Committee

Dr. Milind Javle

Milind Javle, MD


UT MD Anderson Cancer Center

Mitesh Borad, MD

Vice Chair

Mayo Clinic, Arizona


John Bridgewater, PhD

University College London Hospital, UK


Laura Goff, MD

Vanderbilt Ingram Cancer Center

Lipika Goyal

Lipika Goyal, MD

Massachusetts General Hospital/Harvard University

Stacie Lindsey

Stacie Lindsey

Cholangiocarcinoma Foundation


Shishir K. Maithel, MD, FACS

Emory University


Lewis Roberts, MB, ChB, PhD

Mayo Clinic, Minnesota


Flavio Rocha, MD, FACS

Virginia Mason Medical Center


Virote Sriuranpong, MD, PhD

Chulalongkorn University

Advocacy Organization Hybrid Model for Advancing Research

Translate »

Pin It on Pinterest